Frequency Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Korro Bio

15/11/2021 18:11

* Frequency Therapeutics Inc  FREQ.OQ  reported a quarterly
adjusted loss of 73 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 57 cents per share.
* Reported revenue was zero​;  analysts expected $2.38 million. 
* Frequency Therapeutics Inc's reported EPS for the quarter was
a loss of 73 cents​.
* The mean earnings estimate of analysts had risen by about 6.5%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Frequency Therapeutics Inc shares had fallen by 11.6% this
quarter and lost 82.3% so far this year.
* The company reported a quarterly loss of $25.16 million.
* Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $13.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated November 15 at 06:11 p.m.
 ​All figures in US dollars unless otherwise stated